← SynDRA
TENOFOVIR ALAFENAMIDE
SynDRA canonical compound SYN0033269 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | GAG-POL |
|---|
| Mechanism of action | hiv gag inhibitor |
|---|
| Indication | human immunodeficiency virus (hiv-1) |
|---|
| Disease area | Infectious disease |
|---|
All known targets
- GAG-POL
- HIV IN
- HIV RT
- CYP1A2
- CYP3A4
- pol
- reverse transcriptas
- HBcAg
- gag-pol
Mechanisms of action (all sources)
- hiv gag INHIBITOR
- nucleoside reverse transcriptase inhibitor
- HIV RT INHIBITOR
- HIV IN INHIBITOR
- HIV integrase INHIBITOR
- HIV RT MODULATOR
- pol INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Drug classes
- Anti-HIV Agents
- Anti-Infective Agents
- Anti-Retroviral Agents
- Antiviral Agents
- Enzyme Inhibitors
- Nucleic Acid Synthesis Inhibitors
- Reverse Transcriptase Inhibitors
ATC classes
- J05A · DIRECT ACTING ANTIVIRALS
Cross-references
Synonyms
- BIKTARVY
- DESCOVY
- EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE
- EMTRICITABINE, RILPIVIRINE, AND TENOFOVIR ALAFENAMIDE
- GENVOYA
- ODEFSEY
- SYMTUZA
- TENOFOVIR ALAFENAMIDE FUMARATE
- VEMLIDY
- Vemlidy
- GS-7340
- tenofovir alagenamide
- tenofovir alafenamide fumarate
- Tenofovir alafenamida
- Gs-7340
- GS-734003
- GS 7340
- EL9943AG5J
- CHEBI:90926
- TFV Alafenamide
- RefChem:56250
- DTXCID401386833
- MFCD23843796
- UNII-EL9943AG5J
- GS7340
- Tenofovir Alafenamide [USAN]
- Tenofovir Alafenamide (GS-7340)
- C21H29N6O5P
- GS-7339
- Tenofovir Alafenamide [USAN:INN]
- UNII-J4414G3BUK
- orb1305529
- orb3141355
- SCHEMBL3107149
- GS-7340 Tenofovir alafenamide
- SCHEMBL29351625
Reported adverse events
- Vomiting
- Depression
- Nasopharyngitis
- Sinusitis
- Upper respiratory tract infection
- Weight decreased
- Asthenia
- Anxiety
- Myalgia
- Pneumonia
- Pain
- Chest pain
Look up TENOFOVIR ALAFENAMIDE in the interactive SynDRA portal →